We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
11 hedge funds and large institutions have $5.7M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4.68% less ownership
Funds ownership: 20.15% → 15.46% (-4.7%)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$585K | |
| 2 | +$269K | |
| 3 | +$264K | |
| 4 |
RPG
Risk Paradigm Group
Austin,
Texas
|
+$15.8K |
| 5 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
+$9.05K |
Top Sellers
| 1 | -$51.8K | |
| 2 | -$35.1K | |
| 3 | -$17K | |
| 4 |
Morgan Stanley
New York
|
-$2K |